Subscribe To
Tracon pharmaceuticals strikes $35m debt financing facility with runway growth capital
TRACON pharmaceuticals Inc (NASDAQ:TCON) has announced a $35 million non-dilutive long-term debt facili...
September 6, 2022, 8:46 am
Reneo pharmaceuticals to participate at upcoming investor conferences
IRVINE, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Reneo pharmaceuticals, Inc. (NASDAQ: RPHM), a clinic...
September 6, 2022, 8:35 am
Evoke pharma to participate in h.c. wainwright 24th annual global investment conference
SOLANA BEACH, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharma...
September 6, 2022, 8:30 am
Cymabay therapeutics to present at the h.c. wainwright 24th annual global investment conference
NEWARK, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage bio...
September 6, 2022, 8:02 am
Nabriva therapeutics to participate in the h.c. wainwright 24th annual global investment conference
DUBLIN, Ireland and FORT WASHINGTON, Pa., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a bio...
September 6, 2022, 7:01 am
Innocan pharma to participate in the h.c. wainwright 24th annual global investment conference on september 12-14, 2022
Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - September 6, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "C...
September 6, 2022, 3:00 am
Vertex (vrtx) cf drug gets fda expanded label for toddlers
Following FDA approval for label expansion, Vertex pharmaceuticals' (VRTX) Orkambi is now approved for ...
September 5, 2022, 2:18 pm
Avadel pharmaceuticals: navigating through the uncertainty
Avadel pharmaceuticals goes into the spotlight today. This small biopharma company recently got 'tentat...
September 5, 2022, 6:11 am
Day one biopharmaceuticals: recent strong data, and major catalysts ahead
Day One Biopharmaceuticals declared strong data in relapsed glioma in June. The company has strong cash...
September 4, 2022, 12:17 pm
These 3 stocks are the future of biotechnology
Here's why three Fool.com contributors love Vertex pharmaceuticals, Repligen, and Recursion ...
September 4, 2022, 10:36 am
Regulus therapeutics to participate in upcoming investor conferences
SAN DIEGO , Sept. 2, 2022 /PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical...
September 2, 2022, 4:05 pm
The fda's mixed messages sent amylyx pharmaceuticals stock off a cliff
The FDA offered mixed messages Friday for Amylyx pharmaceuticals' experimental neurological disease tre...
September 2, 2022, 1:45 pm
Helix biopharma corp names dr gabrielle siegers as its head of research and development
Helix BioPharma Corp. (TSX:HBP) has announced the appointment of Dr Gabrielle Siegers as its head of research and development based out of the company...
September 2, 2022, 6:39 am
Hillevax to participate in j.p. morgan biotech – 2022 conference call series
BOSTON, Sept. 01, 2022 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical...
September 1, 2022, 5:18 pm
Is veeva systems still a good stock to buy?
The cloud service provider to the biopharmaceutical industry didn't light any fireworks with its second...
September 1, 2022, 11:00 am
Lobe sciences inks us$1.5m investment agreement to fund australian clinical trials
Lobe Sciences Ltd announced that it has entered into a term sheet with Cantheon Capital to raise up US$1.5 million, by means of a convertible note fin...
September 1, 2022, 10:26 am
Avidity biosciences to participate in upcoming investor conferences
SAN DIEGO , Sept. 1, 2022 /PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical ...
September 1, 2022, 9:05 am
Acadia pharmaceuticals to present at upcoming investor conferences
SAN DIEGO--(BUSINESS WIRE)--Acadia pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will par...
September 1, 2022, 9:03 am
Algernon pharmaceuticals says global expert on ipf describes results from phase 2a study on ifenprodil as 'excellent'
Algernon pharmaceuticals Inc. (CSE:AGN, OTCQB:AGNPF) told investors it has now received the full data s...
September 1, 2022, 8:11 am
Immunic, inc. to participate in investor conferences in september
NEW YORK , Sept. 1, 2022 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical...
September 1, 2022, 6:30 am